Talphera (TLPH) EBT Margin Growth (3y) (2014 - 2025)
Talphera (TLPH) EBT Margin Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1,282.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 58.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -861.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -1,020.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -995.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1,157.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Talphera | 90.63 Mn | 90.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -842,748.00 |
| Dec 31, 2023 | -39,658.00 |
| Sep 30, 2023 | -55,748.00 |
| Jun 30, 2023 | -152,323.00 |
| Mar 31, 2023 | 427,837.00 |
| Mar 31, 2022 | 486,001.00 |
| Dec 31, 2021 | -39.38 Mn |
| Sep 30, 2021 | 281,186.00 |
| Jun 30, 2021 | -93,419.00 |
| Mar 31, 2021 | 65,293.00 |
| Dec 31, 2020 | 22,241.00 |
| Sep 30, 2020 | 22,234.00 |
| Jun 30, 2020 | 26,526.00 |
| Mar 31, 2020 | -384,385.00 |
| Dec 31, 2019 | -288,596.00 |
| Sep 30, 2019 | -175,410.00 |
| Jun 30, 2019 | -107,390.00 |
| Mar 31, 2019 | -661,404.00 |
| Dec 31, 2018 | -143,832.00 |
| Sep 30, 2018 | -334,237.00 |